- Home
- KOPN vs CRVS Comparison
KOPN vs CRVS Comparison
Compare KOPN & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOPN
- CRVS
- Stock Information
- Founded
- KOPN 1984
- CRVS 2014
- Country
- KOPN United States
- CRVS United States
- Employees
- KOPN N/A
- CRVS N/A
- Industry
- KOPN Semiconductors
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- KOPN Technology
- CRVS Health Care
- Exchange
- KOPN Nasdaq
- CRVS Nasdaq
- Market Cap
- KOPN 255.1M
- CRVS 305.4M
- IPO Year
- KOPN 1992
- CRVS 2016
- Fundamental
- Price
- KOPN $1.89
- CRVS $5.55
- Analyst Decision
- KOPN Strong Buy
- CRVS Strong Buy
- Analyst Count
- KOPN 2
- CRVS 4
- Target Price
- KOPN $2.63
- CRVS $15.00
- AVG Volume (30 Days)
- KOPN 2.5M
- CRVS 461.1K
- Earning Date
- KOPN 08-12-2025
- CRVS 08-07-2025
- Dividend Yield
- KOPN N/A
- CRVS N/A
- EPS Growth
- KOPN N/A
- CRVS N/A
- EPS
- KOPN N/A
- CRVS N/A
- Revenue
- KOPN $46,959,478.00
- CRVS N/A
- Revenue This Year
- KOPN $8.02
- CRVS N/A
- Revenue Next Year
- KOPN $20.99
- CRVS N/A
- P/E Ratio
- KOPN N/A
- CRVS N/A
- Revenue Growth
- KOPN 13.03
- CRVS N/A
- 52 Week Low
- KOPN $0.56
- CRVS $2.54
- 52 Week High
- KOPN $2.50
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- KOPN 51.83
- CRVS 69.70
- Support Level
- KOPN $1.68
- CRVS $5.03
- Resistance Level
- KOPN $2.04
- CRVS $5.81
- Average True Range (ATR)
- KOPN 0.17
- CRVS 0.32
- MACD
- KOPN -0.02
- CRVS 0.09
- Stochastic Oscillator
- KOPN 38.18
- CRVS 85.22
About KOPN Kopin Corporation
Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).